Peritoneal carcinomatosis with intraperitoneal immunotherapy: current treatment options and perspectives.

The prognosis of PC is poor. However, the peritoneal cavity is a unique immune compartment with abundant immune cells which can produce effective immunity. IP immunotherapy may be a promising strategy in patients with PC.